The stock now trades at one of its lowest price-to-earnings ratios in years. The Danish pharmaceutical giant announced it was ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Celcuity stock (NASDAQ: CELC), a clinical-stage biotechnology company, experienced an extraordinary 3x surge in a single ...

Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

Novo Nordisk A/S stock dips after 2025 guidance cut. However, click for why NVO's strong GLP-1 prospects, growing pipeline, ...

Clinical-stage biotech Recursion Pharmaceuticals ' (NASDAQ: RXRX) stock took it on the chin in the first trading day of the ...

Now, it’s worth noting Stock Advisor’s total average return is 1,041% — a market-crushing outperformance compared to 183 % ...

Consumers are already stretched thin, so rate cuts may not significantly boost spending or spark runaway inflation as many fear. Click for more on U.S. Economy.

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth ...